Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retraction notice to "Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models" [Life Sci. 288 (2022) 120166].
Kiani FK, Izadi S, Dezfouli EA, Ebrahimi F, Mohammadi M, Chalajour H, Bulus MM, Esfahani MN, Karpisheh V, Khesht AMS, Abbaszadeh-Goudarzi K, Soleimani A, Navashenaq JG, Ahmadi M, Hassannia H, Hojjat-Farsangi M, Farid SS, Hashemi V, Jadidi-Niaragh F. Kiani FK, et al. Life Sci. 2024 Aug 1;350:122775. doi: 10.1016/j.lfs.2024.122775. Epub 2024 Jun 8. Life Sci. 2024. PMID: 38851943 No abstract available.
Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Kheshti AMS, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, Noukabadi FK, Kiani FK, Hassannia H, Atyabi F, Kiaie SH, Kashanchi F, Navashenaq JG, Mohammadi H, Bagherifar R, Jafari R, Zolbanin NM, Jadidi-Niaragh F. Kheshti AMS, et al. Among authors: kiani fk. Pharm Res. 2022 Feb;39(2):353-367. doi: 10.1007/s11095-022-03169-2. Epub 2022 Feb 15. Pharm Res. 2022. Retraction in: Pharm Res. 2023 Feb;40(2):615-616. doi: 10.1007/s11095-022-03456-y PMID: 35166995 Retracted.
Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model.
Barshidi A, Karpisheh V, Noukabadi FK, Kiani FK, Mohammadi M, Afsharimanesh N, Ebrahimi F, Kiaie SH, Navashenaq JG, Hojjat-Farsangi M, Zolbanin NM, Mahmoodpoor A, Hassannia H, Nami S, Jalali P, Jafari R, Jadidi-Niaragh F. Barshidi A, et al. Among authors: kiani fk. Pharm Res. 2022 Aug;39(8):1851-1866. doi: 10.1007/s11095-022-03297-9. Epub 2022 Jun 17. Pharm Res. 2022. Retraction in: Pharm Res. 2024 Feb;41(2):407-408. doi: 10.1007/s11095-023-03647-1 PMID: 35715669 Retracted.
Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Salehi AM, Kheshti, Hajizadeh F, Barshidi A, Rashidi B, Ebrahimi F, Bahmanpour S, Karpisheh V, Noukabadi FK, Kiani FK, Hassannia H, Atyabi F, Kiaie SH, Kashanchi F, Navashenaq JG, Mohammadi H, Bagherifar R, Jafari R, Zolbanin NM, Jadidi-Niaragh F. Salehi AM, et al. Among authors: kiani fk. Pharm Res. 2023 Feb;40(2):615-616. doi: 10.1007/s11095-022-03456-y. Pharm Res. 2023. PMID: 36477758 No abstract available.
Corrigendum to "Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy" [Nanomedicine Nanotechnol Biol Med 29 (2020) 102240].
Masjedi A, Ahmadi A, Ghanee S, Malakotikhah F, Afjadi MN, Irandoust M, Kiani FK, Asl SH, Atyabi F, Hassannia H, Hojjat-Farsangi M, Namdar A, Ghalamfarsa G, Jadidi-Niaragh F. Masjedi A, et al. Among authors: kiani fk. Nanomedicine. 2023 Jul;51:102690. doi: 10.1016/j.nano.2023.102690. Epub 2023 May 9. Nanomedicine. 2023. PMID: 37167816 No abstract available.
Retraction Note: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model.
Barshidi A, Karpisheh V, Noukabadi FK, Kiani FK, Mohammadi M, Afsharimanesh N, Ebrahimi F, Kiaie SH, Navashenaq JG, Hojjat-Farsangi M, Zolbanin NM, Mahmoodpoor A, Hassannia H, Nami S, Jalali P, Jafari R, Jadidi-Niaragh F. Barshidi A, et al. Among authors: kiani fk. Pharm Res. 2024 Feb;41(2):407-408. doi: 10.1007/s11095-023-03647-1. Pharm Res. 2024. PMID: 38148385 No abstract available.
Retraction notice to "Codelivery of BV6 and anti-IL6 siRNA by hyaluronate-conjugated PEG-chitosan-lactate nanoparticles inhibits tumor progression" [Life Sci. 260 (2020) 118423].
Salimifard S, Kiani FK, Eshaghi FS, Izadi S, Shahdadnejad K, Masjedi A, Heydari M, Ahmadi A, Hojjat-Farsangi M, Hassannia H, Mohammadi H, Boroumand-Noughabi S, Keramati MR, Jadidi-Niaragh F. Salimifard S, et al. Among authors: kiani fk. Life Sci. 2024 Aug 1;350:122774. doi: 10.1016/j.lfs.2024.122774. Epub 2024 Jun 6. Life Sci. 2024. PMID: 38845262 No abstract available.
The sensitivity of acute myeloid leukemia cells to cytarabine is increased by suppressing the expression of Heme oxygenase-1 and hypoxia-inducible factor 1-alpha.
Sadeghi M, Moslehi A, Kheiry H, Kiani FK, Zarei A, Khodakarami A, Karpisheh V, Masjedi A, Rahnama B, Hojjat-Farsangi M, Raeisi M, Yousefi M, Movasaghpour Akbari AA, Jadidi-Niaragh F. Sadeghi M, et al. Among authors: kiani fk. Cancer Cell Int. 2024 Jun 25;24(1):217. doi: 10.1186/s12935-024-03393-3. Cancer Cell Int. 2024. PMID: 38918761 Free PMC article.
Corrigendum to "Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells" [Int. Immunopharmacol. 101 (2021) 108288].
Fathi M, Bahmanpour S, Barshidi A, Rasouli H, Kiani FK, Khesht AMS, Izadi S, Rashidi B, Kermanpour S, Mokhtarian R, Karpisheh V, Hassannia H, Mohammadi H, Jalili A, Jadidi-Niaragh F. Fathi M, et al. Among authors: kiani fk. Int Immunopharmacol. 2024 Dec 5;142(Pt A):113118. doi: 10.1016/j.intimp.2024.113118. Epub 2024 Sep 12. Int Immunopharmacol. 2024. PMID: 39271379 No abstract available.
13 results